GLP-1 Agonists Intermediate
Mounjaro (Tirzepatide): The Dual Agonist Explained
Mounjaro acts on 2 receptors (GLP-1 + GIP) with -22.5% weight loss in SURMOUNT trials. How it works, results, comparison with 1st and 3rd generation.
16 min read
Articles tagged "surmount-trial"
Explore all articles about "surmount-trial": evidence-based insights, clinical studies, and GLP-1 peptide research. Updated content on GLP-1 Journal.